** CK Life Sciences 0775.HK soars as much as 41.7% to HK$0.68, highest since November 2023
** Stock on course for biggest one-day pct rise since June 2022; fourth biggest pct gainer on HK bourse
** Healthcare and pharma products maker files Original Grant Patent application in Hong Kong and provisional patent application with the U.S. Patent and Trademark Office for its circular mRNA and fusion protein TROP2 cancer vaccines
** Says successful commercialisation of TROP2 cancer vaccine could potentially generate significant economic benefits for co
** Stock up 17.1% YTD
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。